Carlsmed, Inc. (CARL)

Carlsmed, Inc. is a medical technology company headquartered in Carlsbad, California, that develops personalized surgical solutions for spine surgery. The company completed its initial public offering on the Nasdaq in 2025.

Carlsmed's aprevo platform combines patient imaging, software-based surgical planning and 3D printing to produce interbody fusion implants designed for the anatomy of each individual patient. Surgeons use the plans and patient-specific implants in spinal fusion procedures, such as treatments for adult spinal deformity and degenerative conditions of the lumbar spine, with the aim of improving alignment and surgical consistency. The company sells to hospitals and surgeons in the United States.